Stroke and Diabetes: Guidelines and Key Considerations
People living with diabetes are at a higher risk for stroke than those without diabetes. Recent evidence shows that certain drugs have demonstrated an ability to reduce the risk of stroke in individuals with type 2 diabetes.
This module will review data from cardiovascular outcome trials and meta-analyses, along with the recommendations from Diabetes Canada guidelines and the current Canadian Stroke Best Practice Recommendations, for the secondary prevention of stroke to help optimize care in this population.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Society of Endocrinology and Metabolism. You may claim a maximum of 1.0 hour (credits are automatically calculated).
Alice Cheng, MD, FRCPC
Celine Huot, MD, FRCPC
Upon successful completion of this continuing education module, the participant will be better able to:
- Describe the risk of stroke in patients with diabetes.
- Summarize the evidence for different antihyperglycemic agents on stroke reduction.
- Discuss the guidelines recommendations from Diabetes Canada for stroke reduction in people with diabetes.
- Apply an appropriate stroke reduction strategy in patients with diabetes according to Diabetes Canada Guidelines.